FDA Chief Winning Over Skeptics As He Juggles Public Health, Industry Concerns And Wary Staff
In a presidential administration that's been roiled by scandal and confusion, Food and Drug Administration Commissioner Scott Gottlieb is standing out as a "thoughtful" and "deliberate" leader who doesn't want to blow up his agency as some had previously feared.
The New York Times:
F.D.A. Chief Goes Against The Administration Stereotype
Scott Gottlieb, the commissioner of the Food and Drug Administration, came to the job with a résumé straight out of the Trump administration’s playbook. A millionaire with a libertarian bent, he made his money working for the industry he now regulates, and had investments in 20 health care companies whose products could come before the agency for approval. Pharmaceutical and medical device executives enthusiastically supported his nomination, while consumer and public health groups sounded the requisite alarms. (Kaplan and Thomas, 2/11)
In other administration news —
How Will CDC Cuts Affect Health Programs Abroad And At Home?
The Centers for Disease Control and Prevention have recently lost hundreds of millions of dollars in funding cuts, including a $750 million cut in December. On Friday, President Trump signed a bill that slashed $1.35 billion from its Prevention and Public Health Fund over the next 10 years. (Yeager, 2/11)